These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25913765)

  • 21. Insulin-like growth factor-I and cognitive function in healthy older men.
    Aleman A; Verhaar HJ; De Haan EH; De Vries WR; Samson MM; Drent ML; Van der Veen EA; Koppeschaar HP
    J Clin Endocrinol Metab; 1999 Feb; 84(2):471-5. PubMed ID: 10022403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between serum insulin-like growth factor 1 and cognitive impairments in patients with schizophrenia.
    Chao XL; Jiang SZ; Xiong JW; Zhan JQ; Yan K; Yang YJ; Jiang LP
    Psychiatry Res; 2020 Mar; 285():112731. PubMed ID: 31839419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma insulin-like growth factor 1 is associated with cognitive impairment in Parkinson's disease.
    Ma J; Jiang Q; Xu J; Sun Q; Qiao Y; Chen W; Wu Y; Wang Y; Xiao Q; Liu J; Tang H; Chen S
    Dement Geriatr Cogn Disord; 2015; 39(5-6):251-6. PubMed ID: 25661865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men.
    Aleman A; de Vries WR; de Haan EH; Verhaar HJ; Samson MM; Koppeschaar HP
    Neuropsychobiology; 2000 Jan; 41(2):73-8. PubMed ID: 10644927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis.
    Arwert LI; Deijen JB; Drent ML
    Growth Horm IGF Res; 2005 Dec; 15(6):416-22. PubMed ID: 16256385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midlife plasma insulin-like growth factor I and cognitive function in older men.
    Okereke OI; Kang JH; Ma J; Gaziano JM; Grodstein F
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4306-12. PubMed ID: 16912125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of the hopkins Verbal Test-Revised for detecting Alzheimer's disease and mild cognitive impairment in Spanish population.
    González-Palau F; Franco M; Jiménez F; Parra E; Bernate M; Solis A
    Arch Clin Neuropsychol; 2013 May; 28(3):245-53. PubMed ID: 23384601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.
    Claxton A; Baker LD; Hanson A; Trittschuh EH; Cholerton B; Morgan A; Callaghan M; Arbuckle M; Behl C; Craft S
    J Alzheimers Dis; 2015; 44(3):897-906. PubMed ID: 25374101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum leptin levels are associated with cognitive function in older adults.
    Gunstad J; Spitznagel MB; Keary TA; Glickman E; Alexander T; Karrer J; Stanek K; Reese L; Juvancic-Heltzel J
    Brain Res; 2008 Sep; 1230():233-6. PubMed ID: 18675793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.
    Picillo M; Pivonello R; Santangelo G; Pivonello C; Savastano R; Auriemma R; Amboni M; Scannapieco S; Pierro A; Colao A; Barone P; Pellecchia MT
    PLoS One; 2017; 12(10):e0186508. PubMed ID: 29065116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between small cerebral white matter lesions and cognitive function in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Makino T; Umegaki H; Suzuki Y; Yanagawa M; Nonogaki Z; Nakashima H; Kuzuya M
    Geriatr Gerontol Int; 2014 Oct; 14(4):819-26. PubMed ID: 24215176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of IGF-I, IGF-II, and IGFBP-3 in male cognitive aging and dementia risk: the Caerphilly Prospective Study.
    Green CJ; Holly JM; Bayer A; Fish M; Ebrahim S; Gallacher J; Ben-Shlomo Y
    J Alzheimers Dis; 2014; 41(3):867-75. PubMed ID: 24705546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities.
    Ball SL; Holland AJ; Treppner P; Watson PC; Huppert FA
    Br J Clin Psychol; 2008 Mar; 47(Pt 1):1-29. PubMed ID: 17681112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-1 (IGF-1): relation with cognitive functioning and neuroimaging marker of brain damage in a sample of hypertensive elderly subjects.
    Angelini A; Bendini C; Neviani F; Bergamini L; Manni B; Trenti T; Rovati R; Neri M
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():5-12. PubMed ID: 19836610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interactive Physical and Cognitive Exercise System (iPACES™): effects of a 3-month in-home pilot clinical trial for mild cognitive impairment and caregivers.
    Anderson-Hanley C; Stark J; Wall KM; VanBrakle M; Michel M; Maloney M; Barcelos N; Striegnitz K; Cohen BD; Kramer AF
    Clin Interv Aging; 2018; 13():1565-1577. PubMed ID: 30233154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of functional tasks exercise on older adults with cognitive impairment at risk of Alzheimer's disease: a randomised controlled trial.
    Law LL; Barnett F; Yau MK; Gray MA
    Age Ageing; 2014 Nov; 43(6):813-20. PubMed ID: 24850540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiating illiteracy from Alzheimer's disease by using neuropsychological assessments.
    Youn JH; Siksou M; Mackin RS; Choi JS; Chey J; Lee JY
    Int Psychogeriatr; 2011 Dec; 23(10):1560-8. PubMed ID: 21777502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased Levels of Serum IGF-1 and Vitamin D Are Associated With Cognitive Impairment in Patients With Type 2 Diabetes.
    Rui-Hua C; Yong-de P; Xiao-Zhen J; Chen J; Bin Z
    Am J Alzheimers Dis Other Demen; 2019; 34(7-8):450-456. PubMed ID: 31319676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the component processes involved in verbal declarative memory function in bipolar disorder: utility of the Hopkins Verbal Learning Test-Revised.
    Van Rheenen TE; Rossell SL
    J Int Neuropsychol Soc; 2014 Aug; 20(7):727-35. PubMed ID: 24870365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.